{"DataElement":{"publicId":"7114357","version":"1","preferredName":"Tumor Mass Low Grade Glioma Histologic Type","preferredDefinition":"The type of tissue in which a carcinoma arising from a Low Grade Glioma originated.","longName":"6796606v1.0:7113061v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796606","version":"1","preferredName":"Tumor Mass Histologic Type","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._Refers to the type of tissue in which a tumor originated.","longName":"4976411v1.0:2673286v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673286","version":"1","preferredName":"Histologic Type","preferredDefinition":"Refers to the type of tissue in which a tumor originated.","longName":"C61478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C878-7530-31CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8C3F2573-4FAB-6BB5-E053-F662850AE327","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Upd RD to \"Qualified\"; CPTAC released AI. 1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF. 7/26/19 jk Updated OC term to Tumor Mass; used on multiple CPTAC CRFs.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7113061","version":"1","preferredName":"Low Grade Glioma Histologic Type","preferredDefinition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma._Refers to the type of tissue in which a tumor originated._Something distinguishable as an identifiable class based on common qualities.","longName":"7113061v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Oligodendroglioma, NOS","valueDescription":"Oligodendroglioma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698554","version":"1","preferredName":"Oligodendroglioma, Not Otherwise Specified","longName":"5698554","preferredDefinition":"An oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma, Not Otherwise Specified","conceptCode":"C129319","definition":"A central nervous system tumor with morphological features of oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B1D1-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-77B3-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Oligodendroglioma, IDH Mutant and 1p / 19q Codeleted","valueDescription":"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","ValueMeaning":{"publicId":"5698556","version":"1","preferredName":"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","longName":"5698556","preferredDefinition":"An oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","conceptCode":"C129318","definition":"An oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B1F7-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-77C8-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Oligoastrocytoma, NOS","valueDescription":"Oligoastrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698558","version":"1","preferredName":"Oligoastrocytoma, Not Otherwise Specified","longName":"5698558","preferredDefinition":"A diffuse glioma characterized by the presence of both an astrocytic and an oligodendroglial component and the absence of information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligoastrocytoma, Not Otherwise Specified","conceptCode":"C129323","definition":"A central nervous system tumor with morphological features of oligoastrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B21D-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-77D3-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Anaplastic Oligodendroglioma, NOS","valueDescription":"Anaplastic Oligodendroglioma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698578","version":"1","preferredName":"Anaplastic Oligodendroglioma, Not Otherwise Specified","longName":"5698578","preferredDefinition":"An anaplastic oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma, Not Otherwise Specified","conceptCode":"C129322","definition":"A central nervous system tumor with morphological features of anaplastic oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B3B7-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-77E8-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Anaplastic Oligoastrocytoma, NOS","valueDescription":"Anaplastic Oligoastrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698582","version":"1","preferredName":"Anaplastic Oligoastrocytoma, Not Otherwise Specified","longName":"5698582","preferredDefinition":"A diffuse anaplastic glioma characterized by the presence of both an astrocytic and an oligodendroglial component and the absence of information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligoastrocytoma, Not Otherwise Specified","conceptCode":"C129324","definition":"A central nervous system tumor with morphological features of anaplastic oligoastrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B403-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-77FD-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Anaplastic Oligodendroglioma, IDH mutant and 1p / 19q codeleted","valueDescription":"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","ValueMeaning":{"publicId":"5698580","version":"1","preferredName":"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","longName":"5698580","preferredDefinition":"An anaplastic oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","conceptCode":"C129321","definition":"An anaplastic oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B3DD-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-7812-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Anaplastic Astrocytoma, NOS","valueDescription":"Anaplastic Astrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698584","version":"1","preferredName":"Anaplastic Astrocytoma, Not Otherwise Specified","longName":"5698584","preferredDefinition":"Anaplastic astrocytoma in which there is insufficient information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma, Not Otherwise Specified","conceptCode":"C129292","definition":"A central nervous system tumor with morphological features of anaplastic astrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B429-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-7827-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Anaplastic Astrocytoma, IDH-Wildtype","valueDescription":"Anaplastic Astrocytoma, IDH-Wildtype","ValueMeaning":{"publicId":"5698586","version":"1","preferredName":"Anaplastic Astrocytoma, IDH-Wildtype","longName":"5698586","preferredDefinition":"Anaplastic astrocytoma lacking mutations in IDH1 or IDH2 genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma, IDH-Wildtype","conceptCode":"C129291","definition":"Anaplastic astrocytoma lacking mutations in IDH1 or IDH2 genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B44F-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-783C-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Anaplastic Astrocytoma, IDH Mutant","valueDescription":"Anaplastic Astrocytoma, IDH-Mutant","ValueMeaning":{"publicId":"5698588","version":"1","preferredName":"Anaplastic Astrocytoma, IDH-Mutant","longName":"5698588","preferredDefinition":"Anaplastic astrocytoma carrying IDH mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Astrocytoma, IDH-Mutant, Grade 3","conceptCode":"C129290","definition":"IDH-mutant astrocytoma characterized by the presence of increased mitotic activity and anaplastic features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B475-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-7851-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Gemistocytic Astrocytoma, IDH Mutant","valueDescription":"Gemistocytic Astrocytoma, IDH-Mutant","ValueMeaning":{"publicId":"5698566","version":"1","preferredName":"Gemistocytic Astrocytoma, IDH-Mutant","longName":"5698566","preferredDefinition":"Gemistocytic astrocytoma carrying IDH mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gemistocytic Astrocytoma, IDH-Mutant","conceptCode":"C129272","definition":"Gemistocytic astrocytoma carrying IDH mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B2D3-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-7866-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Diffuse Astrocytoma, NOS","valueDescription":"Diffuse Astrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698572","version":"1","preferredName":"Diffuse Astrocytoma, Not Otherwise Specified","longName":"5698572","preferredDefinition":"Diffuse astrocytoma in which there is insufficient information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma, Not Otherwise Specified","conceptCode":"C129277","definition":"A central nervous system tumor with morphological features of diffuse astrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B345-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-787B-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Diffuse Astrocytoma, IDH-Wildtype","valueDescription":"Diffuse Astrocytoma, IDH-Wildtype","ValueMeaning":{"publicId":"5698574","version":"1","preferredName":"Diffuse Astrocytoma, IDH-Wildtype","longName":"5698574","preferredDefinition":"Diffuse astrocytoma lacking mutations in IDH1 or IDH2 genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma, IDH-Wildtype","conceptCode":"C129274","definition":"Diffuse astrocytoma lacking mutations in IDH1 or IDH2 genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B36B-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-7890-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Diffuse Astrocytoma, IDH Mutant","valueDescription":"Diffuse Astrocytoma, IDH-Mutant","ValueMeaning":{"publicId":"5698576","version":"1","preferredName":"Diffuse Astrocytoma, IDH-Mutant","longName":"5698576","preferredDefinition":"Diffuse astrocytoma carrying IDH mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Astrocytoma, IDH-Mutant, Grade 2","conceptCode":"C129271","definition":"IDH-mutant astrocytoma characterized by the presence of well-differentiated fibrillary glial cells diffusely infiltrating the central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B391-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A790DB9-78A5-55AC-E053-F662850ABF73","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Histologic Type","ValueMeaning":{"publicId":"7331757","version":"1","preferredName":"Other Histologic Type","longName":"7331757","preferredDefinition":"A selected option that indicated an other histologic type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Histologic Type","conceptCode":"C159613","definition":"A selected option that indicated an other histologic type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80C0DF2-F90A-58A8-E053-4EBD850A7EC2","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80C73DE-3922-758F-E053-4EBD850A86BE","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7113060","version":"1","preferredName":"Low Grade Glioma Histologic Type Type","preferredDefinition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.:Refers to the type of tissue in which a tumor originated.:Something distinguishable as an identifiable class based on common qualities.","longName":"C132067:C61478:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Glioma","conceptCode":"C132067","definition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A790DB9-778A-55AC-E053-F662850ABF73","latestVersionIndicator":"Yes","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A790DB9-779B-55AC-E053-F662850ABF73","latestVersionIndicator":"Yes","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"KNABLEJ","dateModified":"2020-06-14","changeDescription":"6/14/20 jk upd Other PV to use CPTAC CUI for \"Other Histologic Type\".   5/14/20 jk Released per SME (NGM) review and approval email.  12/24/19 jk created for CPTAC LGG baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6601275","version":"1","longName":"Brain","context":"OCCPR"},{"publicId":"6779544","version":"1","longName":"LGG Baseline","context":"OCCPR"},{"publicId":"6779546","version":"1","longName":"LGG Pathology Review","context":"OCCPR"},{"publicId":"6779545","version":"1","longName":"LGG Local Pathology","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB4204F-216F-59E4-E053-F662850AAF97","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-05-14","changeDescription":"5/14/20 jk Released per SME (NGM) review and approval email.  4/30/20 jk added CPTAC LGG Path CSI.  12/27/19 jk created for CPTAC LGG baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}